drisapersen

M&A

Sanofi

Why BioMarin’s Bad News is Great for Sarepta

Barron's

Wed, 06/1/16 - 09:43 pm

BioMarin Fails to Win Approval for Drug to Treat Deadly Duchenne

Bloomberg

Thu, 01/14/16 - 10:07 am

BioMarin Announces That FDA Has Advised it Will Not Take Action on the Kyndrisa™ (drisapersen) New Drug Application by the PDUFA Date

Yahoo

Fri, 12/18/15 - 09:07 am

FDA Committee Raises Concerns about Kyndrisa’s Efficacy, Safety

Yahoo/Market Realist

Fri, 12/11/15 - 10:27 pm

BioMarin: So You’re Saying There’s a Chance?

Barron's

Wed, 11/25/15 - 11:31 am

BioMarin Duchenne drug appears destined for failure after brutal FDA meeting

BioPharma Dive

Wed, 11/25/15 - 10:53 am

advisory panels

The first drug for Duchenne will be reviewed at the FDA today: Why it matters

Bizjournals.com

Tue, 11/24/15 - 09:51 am

advisory panels

BioMarin FDA Panel Live Blog

TheStreet.com

Tue, 11/24/15 - 09:06 am

advisory panels

Duchenne moms say FDA documents ‘widen the divide’ between drugs by BioMarin, Sarepta

Bizjournals.com

Fri, 11/20/15 - 06:19 pm

FDA staff unveils strongly critical review of BioMarin Duchenne drug ahead of crucial meeting

BioPharma Dive

Fri, 11/20/15 - 11:11 am

Experts say Sarepta has a clear edge over BioMarin in Duchenne drug battle

Bizjournals.com

Thu, 11/5/15 - 12:47 pm

FDA ‘Weirdness?’ Separate meetings for BioMarin and Sarepta DMD drugs

Pharmalot

Thu, 10/15/15 - 03:59 pm

Sarepta’s competitor on Duchenne drug could get a two-month head start on sales

Bizjournals.com

Wed, 10/14/15 - 02:23 pm

Sarepta Therapeutics vs. BioMarin Pharmaceutical: Which Company Will Win the DMD Race?

Motley Fool

Tue, 10/6/15 - 07:13 pm

Sarepta snags priority review status to keep pace with BioMarin in DMD race

Fierce Biotech

Wed, 08/26/15 - 09:28 am

priority review

BioMarin's Big Bet on Muscular Dystrophy Is Already Paying Off

Motley Fool

Sat, 08/22/15 - 09:01 am

BioMarin outlines its R&D game plan as Duchenne MD decision nears

Fierce Biotech

Tue, 08/4/15 - 05:51 pm

R&D